Thromboprophylaxis with the Low-Molecular-Weight Heparin Bemiparin Sodium in Elderly Medical Patients in Usual Clinical Practice: The ANCIANOS Study

Author： Rodríguez-Mañas Leocadio  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.5, 2010-05, pp. : 337-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utilisation and Safety of Bemiparin, a Low-Molecular-Weight Heparin, in Medical Patients: A Prospective, Uncontrolled Cohort Study

By Miras-Parra Francisco  

Clinical Drug Investigation, Vol. 25, Iss. 7, 2005-01 ,pp. : 463-472

Adis International

Access to resources Recommend Favorite

Effect of Prophylactic Treatment with Low-Molecular-Weight Heparin Bemiparin Sodium on Serum Potassium Levels: A Prospective Observational Study

By Torres Olga H.  

Drugs & Aging, Vol. 27, Iss. 5, 2010-05 ,pp. : 399-406

Adis International

Access to resources Recommend Favorite

Reviparin sodium – a new low molecular weight heparin

By Breddin Hans Klaus  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 173-182

Informa Healthcare

Access to resources Recommend Favorite

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien   Gajdziok Jan   Rabišková Miloslava   Bonneaux François   Lecompte Thomas   Sapin Anne   Maincent Philippe  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin in Acute Coronary Syndromes

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite